{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:42:08Z","timestamp":1772160128230,"version":"3.50.1"},"reference-count":46,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100010564","name":"Academic Medical Organization of Southwestern Ontario","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008958","name":"Lawson Health Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000226","name":"Ontario Ministry of Health and Long-Term Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008093","name":"Schulich School of Medicine and Dentistry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004381","name":"Western University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004381","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dom-pubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To examine trends in basal insulin prescribing in older adults with chronic kidney disease (CKD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>We conducted a population\u2010based study of adults aged 66\u2009years or older with treated diabetes from 1 January 2010 to 30 September 2020 in Ontario, Canada. We examined prevalent and incident prescriptions for human NPH, Levemir, glargine\u2010100, Basaglar, glargine\u2010300, and degludec insulin over 43 study intervals. We present trends in those with CKD, and in a subgroup, by estimated glomerular filtration rate (eGFR). To provide context for prescribing, we provide demographics, co\u2010morbidities, and the healthcare utilization of included patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In CKD, use of basal insulin was about 2\u2010fold higher than in the general treated diabetes cohort. Prescriptions for NPH declined over time, while prescriptions for Levemir and glargine\u2010100 increased until 2018 then decreased. Following drug formulary approval (September 2018), prescriptions for glargine\u2010300 and degludec increased substantially. Incident prescriptions for basal insulin in CKD declined over time; however, in those with an eGFR of less than 30\u2009ml\/min\/1.73m\n                      <jats:sup>2<\/jats:sup>\n                      , rates remained stable. In recent years, rates of degludec and glargine\u2010300 have rivalled glargine\u2010100.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In an era of new oral and injectable diabetes medications, the use of basal insulin has declined in older adults with CKD. However, in those with more advanced CKD, basal insulin, particularly newer analogues, remain a mainstay treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/dom.14622","type":"journal-article","created":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T23:41:11Z","timestamp":1639525271000},"page":"641-651","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Trends in basal insulin prescribing in older adults with chronic kidney disease in Ontario, Canada: A population\u2010based analysis from 2010 to 2020"],"prefix":"10.1111","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9636-5597","authenticated-orcid":false,"given":"Kristin K.","family":"Clemens","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Endocrinology and Metabolism Western University  London Ontario Canada"},{"name":"Department of Epidemiology and Biostatistics Western University  London Ontario Canada"},{"name":"ICES  London Ontario Canada"},{"name":"St. Joseph's Healthcare London  London Ontario Canada"},{"name":"Lawson Health Research Institute  London Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra M.","family":"Ou\u00e9draogo","sequence":"additional","affiliation":[{"name":"ICES  London Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melody","family":"Lam","sequence":"additional","affiliation":[{"name":"ICES  London Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flory Tsobo","family":"Muanda","sequence":"additional","affiliation":[{"name":"ICES  London Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Loeschnik","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics Western University  London Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Wilk","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics Western University  London Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salimah Z.","family":"Shariff","sequence":"additional","affiliation":[{"name":"ICES  London Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2022,1,11]]},"reference":[{"key":"e_1_2_9_2_1","volume-title":"Product Monograph Novolin Ge","author":"Novo Nordisk Canada","year":"2016"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-019-00925-6"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12782"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12032"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.2337\/db18-107-OR"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-019-05080-9"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2009.02670.x"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-019-1128-3"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2016.11.019"},{"key":"e_1_2_9_11_1","first-page":"1045","article-title":"Basal insulins and advanced renal failure: time for a paradigm shift","volume":"69","author":"Chaudhuri SR","year":"2020","journal-title":"ADA Abstr."},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfz023"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2019.107423"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2009.10.020"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12658"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k3532"},{"issue":"2","key":"e_1_2_9_17_1","first-page":"3","article-title":"Development of the Canadian marginalization index: a new tool for the study of inequality","volume":"103","author":"Matheson FI","year":"2012","journal-title":"Can J Public Heal."},{"key":"e_1_2_9_18_1","unstructured":"Public Health Ontario. 2011 Ontario Marginalization Index: Technical Document; 2017.https:\/\/www.publichealthontario.ca\/en\/data\u2010and\u2010analysis\/health\u2010equity\/ontario\u2010marginalization\u2010index. Accessed August 15 2021."},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/15412550903140865"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.24095\/hpcdp.33.3.06"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/963098"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.9778\/cmajo.20190065"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-14-81"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2012.07.005"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-2294"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13528"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4878"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.7117"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.4158\/EP13287.OR"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-018-1258-0"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14549"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1811744"},{"key":"e_1_2_9_33_1","unstructured":"Diabetes Canada. Clinical Practice Guidelines \u2010 Chapter 13: Pharmacologic Glycemic Management of Type 2 Diabetes in Adults:2020update.http:\/\/guidelines.diabetes.ca\/cpg\/chapter-13-2020-update. Accessed November 15 2021."},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjd.2020.09.005"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12805"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-019-00735-7"},{"key":"e_1_2_9_37_1","first-page":"105\u2010114","article-title":"The health and healthcare of adults with type 1 and 2 diabetes across the estimated glomerular filtration rate spectrum","volume":"43","author":"Clemens KK","year":"2018","journal-title":"Can J Diabetes."},{"issue":"4","key":"e_1_2_9_38_1","article-title":"Opportunties to improve diabetes care in the hemodialysis unit: a cohort study in Ontario, Canada","volume":"2","author":"Clemens KK","year":"2021","journal-title":"Kidney 360"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2015-000184"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4422-0"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.4158\/EP11371.OR"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12503"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13677"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2017.11.002"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12886"},{"key":"e_1_2_9_46_1","unstructured":"Diabetes CanadaClinical Practice Guidelines \u2010 Chapter 29: Chronic Kidney Disease in Diabetes.https:\/\/guidelines.diabetes.ca\/cpg\/chapter29. Accessed August 6 2019."},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004080697"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dom.14622","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dom.14622","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/pdf\/10.1111\/dom.14622","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:18:42Z","timestamp":1761862722000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/10.1111\/dom.14622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,11]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10.1111\/dom.14622"],"URL":"https:\/\/doi.org\/10.1111\/dom.14622","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.1111\/DOM.14622\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.14622\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.14622\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.14622\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.14622\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.14622\/v1\/decision1","asserted-by":"object"}]},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"value":"1462-8902","type":"print"},{"value":"1463-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,11]]},"assertion":[{"value":"2021-09-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}